Benjamin Matthew Fink - 27 Feb 2026 Form 4 Insider Report for Innovex International, Inc. (INVX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 19:00:10 UTC
Prior SEC filing
18 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matt Steinheider, Attorney-in-Fact

Key filing fact

Benjamin Matthew Fink filed Form 4 for Innovex International, Inc. (INVX) on 03 Mar 2026.

Key facts

  • This page summarizes Benjamin Matthew Fink's Form 4 filing for Innovex International, Inc. (INVX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2026, 19:00.

Change

  • Previous filing in this sequence was filed on 18 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001312482 Primary reporting owner

Fink Benjamin Matthew

Relationship
Director
Address
19120 KENSWICK DR., HUMBLE
Signature
/s/ Matt Steinheider, Attorney-in-Fact
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INVX transaction

Common Stock

Award

Transaction value
$0
Shares
+5,465
Change %
+34%
Price
$0.000000
Shares after
21,376
Date
27 Feb 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .